Jennison Associates LLC Sage Therapeutics, Inc. Transaction History

Jennison Associates LLC

$149 Billion
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$40.26 - $57.37 $23.4 Million - $33.4 Million	-582,120 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$54.88 - $79.29 $1.24 Million - $1.79 Million	22,594 Added 4.04%	582,120 $33.1 Million
Q1 2021 May 11, 2021	SELL	$70.65 - $96.76 $313,827 - $429,807	-4,442 Reduced 0.79%	559,526 $41.9 Million
Q4 2020 Feb 05, 2021	BUY	$58.41 - $89.06 $7.34 Million - $11.2 Million	125,603 Added 28.65%	563,968 $48.8 Million
Q3 2020 Nov 04, 2020	BUY	$41.13 - $62.45 $9.05 Million - $13.7 Million	220,127 Added 100.87%	438,365 $26.8 Million

Q2 2020 Aug 06, 2020	BUY	$25.95 - $43.15 $14,817 - $24,638	571 Added 0.26%	218,238 $9.07 Million
Q1 2020 May 06, 2020	SELL	$26.15 - $77.24 $5.58 Million - $16.5 Million	-213,542 Reduced 49.52%	217,667 $6.25 Million
Q4 2019 Feb 07, 2020	SELL	$60.18 - $154.77 $145 Million - $373 Million	-2,412,480 Reduced 84.84%	431,209 $31.1 Million
Q3 2019 Nov 08, 2019	SELL	$140.29 - $189.96 $15.5 Million - $20.9 Million	-110,224 Reduced 3.73%	2,843,689 $399 Million
Q2 2019 Aug 06, 2019	BUY	$157.85 - $183.09 $94.4 Million - $110 Million	598,299 Added 25.4%	2,953,913 $0
Q1 2019 May 10, 2019	BUY	$89.33 - $163.65 $135 Million - $247 Million	1,509,950 Added 178.55%	2,355,614 $375 Million
Q4 2018 Feb 06, 2019	BUY	$81.94 - $139.71 $2.9 Million - $4.95 Million	35,440 Added 4.37%	845,664 $81 Million
Q3 2018 Nov 08, 2018	BUY	$138.11 - $169.04 $671,628 - $822,041	4,863 Added 0.6%	810,224 $114 Million
Q2 2018 Aug 02, 2018	BUY	$140.36 - $175.76 $2.01 Million - $2.52 Million	14,338 Added 1.81%	805,361 $126 Million
Q1 2018 Apr 20, 2018	BUY	$152.15 - $192.33 $17.1 Million - $21.6 Million	112,316 Added 16.55%	791,023 $127 Million
Q4 2017 Jan 25, 2018	SELL	$60.72 - $167.34 $11.8 Million - $32.6 Million	-195,043 Reduced 22.32%	678,707 $112 Million
Q3 2017 Nov 03, 2017	BUY	$61.4 - $88.52 $53.6 Million - $77.3 Million	873,750	873,750 $54.4 Million

Others Institutions Holding SAGE

# of Institutions

222

Shares Held

52.7M

Call Options Held

207K

Put Options Held

191K

Vanguard Group Inc Valley Forge, PA

5.75M
Shares

$62 Million
0.0% of portfolio
Rtw Investments, LP New York, NY

5.48M
Shares

$59.1 Million
1.65% of portfolio
Black Rock Inc. New York, NY

4.89M
Shares

$52.7 Million
0.0% of portfolio
Wellington Management Group LLP Boston, MA

4.75M
Shares

$51.2 Million
0.02% of portfolio
State Street Corp Boston, MA

4.49M
Shares

$48.5 Million
0.0% of portfolio

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $641M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Account